Truist: 'We Remain Bullish on Ardent Health Partners Inc (ARDT)'

Truist Securities analyst David MacDonald reiterated a Buy rating and $21.00 price target on Ardent Health Partners Inc (NYSE: ARDT).

Tghe analyst commented: "We remain bullish on Ardent following upbeat management meetings highlighting the company's strong positioning in attractive markets and ample opportunity for continued growth, footprint expansion and margin improvement. Ongoing technology and productivity investments should provide solid benefits in key areas (labor, margins, patient experience, quality) coupled with improved regulatory clarity following the passage of OBBB. Solid cash flow and financial flexibility should support continued execution on the wide range of initiatives and capital deployment while leverage continues to improve. We reiterate our Buy rating and $21 price target."

For an analyst ratings summary and ratings history on Ardent Health Partners Inc click here. For more ratings news on Ardent Health Partners Inc click here.

Shares of Ardent Health Partners Inc closed at $13.31 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results